Literature DB >> 24777587

Diagnostic value of strain echocardiography, galectin-3, and tenascin-C levels for the identification of patients with pulmonary and cardiac sarcoidosis.

Seref Kul1, Hatice Kutbay Ozcelik, Huseyin Uyarel, Gultekin Karakus, Tolga Sinan Guvenc, Murat Yalcınsoy, Emin Asoglu, Ahu Sarbay Kemik, Abdurrahman Tasal, Sinem Gungor, Ercan Karaarslan, Levent Kart, Omer Goktekin.   

Abstract

BACKGROUND: Cardiac involvement in sarcoidosis has been associated with poor prognosis. We evaluated myocardial contractility quantitatively in a cohort of pulmonary sarcoidosis (PS) patients with and without cardiac involvement. We also studied markers of fibrosis (tenascin-C [Tn-C] and galectin-3 [Gl-3]) as diagnostic tools for PS and cardiac sarcoidosis (CS).
METHODS: Forty ambulatory patients with PS of grades 1-2 and 26 healthy subjects were prospectively enrolled. All patients with PS underwent cardiac magnetic resonance (CMR) to explore the presence of CS. The study population was divided into three groups: controls (n = 26), non-CS patients (n = 34), and CS patients (n = 6). Speckle-tracking strain echocardiography (STE) was performed on all patients, and Gl-3 and Tn-C values were measured in all patients and controls.
RESULTS: PS patients had higher levels of Gl-3 and Tn-C than did controls, and the STE parameters of PS patients, including global longitudinal strain (GLS) and global circumferential strain (GCS), were lower than those of controls (p < 0.001 for all comparisons). GLS values were lower in CS patients than in the other groups (p = 0.05).
CONCLUSIONS: PS patients demonstrate reduced cardiac contractility, independent of CMR-proven structural cardiac lesions, while patients with structural lesions have a more pronounced drop in strain parameters. Tn-C and Gl-3 are promising markers for the diagnosis of PS, but they are not specific for cardiac involvement.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24777587     DOI: 10.1007/s00408-014-9586-5

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  34 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Myocardial mechanics for the early detection of cardiac sarcoidosis.

Authors:  Constantina Aggeli; Ioannis Felekos; Dimitris Tousoulis; Elias Gialafos; Aggeliki Rapti; Christodoulos Stefanadis
Journal:  Int J Cardiol       Date:  2013-07-17       Impact factor: 4.164

3.  Differential effects of coronary artery stenosis on myocardial function: the value of myocardial strain analysis for the detection of coronary artery disease.

Authors:  Sara Shimoni; Gera Gendelman; Oded Ayzenberg; Nahum Smirin; Peter Lysyansky; Orly Edri; Lisa Deutsch; Avraham Caspi; Zvi Friedman
Journal:  J Am Soc Echocardiogr       Date:  2011-04-20       Impact factor: 5.251

Review 4.  Sarcoidosis.

Authors:  L S Newman; C S Rose; L A Maier
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

5.  NT-proatrial natriuretic peptide as a possible biomarker of cardiopulmonary involvement in sarcoidosis.

Authors:  Damiano Magrì; Piergiuseppe Agostoni; Agnese Ricotta; Lara Pisani; Filippo Maria Cauti; Alessandro Onofri; Pierdonato Bruno; Alberto Ricci; Massimo Volpe; Simona Marchitti; Salvatore Mariotta; Speranza Rubattu
Journal:  Eur J Intern Med       Date:  2013-01-05       Impact factor: 4.487

Review 6.  The role of tenascin C in cardiovascular disease.

Authors:  Jonathan Golledge; Paula Clancy; Jane Maguire; Lisa Lincz; Simon Koblar
Journal:  Cardiovasc Res       Date:  2011-06-28       Impact factor: 10.787

7.  Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.

Authors:  A Rogier van der Velde; Lars Gullestad; Thor Ueland; Pål Aukrust; Yu Guo; Aram Adourian; Pieter Muntendam; Dirk J van Veldhuisen; Rudolf A de Boer
Journal:  Circ Heart Fail       Date:  2013-02-08       Impact factor: 8.790

8.  Impaired aortic elastic properties in patients with systemic sarcoidosis.

Authors:  I Moyssakis; E Gialafos; N Tentolouris; C S Floudas; T G Papaioannou; Ch Kostopoulos; P Latsi; G Vaiopoulos; V Votteas; A Rapti
Journal:  Eur J Clin Invest       Date:  2008-02       Impact factor: 4.686

9.  Capability of three-dimensional speckle tracking radial strain for identification of patients with cardiac sarcoidosis.

Authors:  Takayuki Tsuji; Hidekazu Tanaka; Kensuke Matsumoto; Tatsuya Miyoshi; Mana Hiraishi; Akihiro Kaneko; Keiko Ryo; Yuko Fukuda; Kazuhiro Tatsumi; Tetsuari Onishi; Hiroya Kawai; Ken-ich Hirata
Journal:  Int J Cardiovasc Imaging       Date:  2012-08-01       Impact factor: 2.357

10.  Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis.

Authors:  T Suzuki; T Kanda; S Kubota; S Imai; K Murata
Journal:  Chest       Date:  1994-10       Impact factor: 9.410

View more
  9 in total

1.  Assessment of right ventricular geometry and mechanics in chronic obstructive pulmonary disease patients living at high altitude.

Authors:  Tolga Sinan Güvenç; Seref Kul; Coşkun Doğan; Binnaz Zeynep Yıldırım; Yavuz Karabağ; Rengin Cetin; Yüksel Kaya; Pelin Karadağ; Aleks Değirmencioğlu; Bahattin Balcı
Journal:  Int J Cardiovasc Imaging       Date:  2014-06-21       Impact factor: 2.357

2.  Early Detection of Bi-ventricular and Atrial Mechanical Dysfunction Using Two-Dimensional Speckle Tracking Echocardiography in Patients with Sarcoidosis.

Authors:  Kursat Tigen; Murat Sunbul; Tansu Karaahmet; Onur Tasar; Cihan Dundar; Murat Yalcinsoy; Mumtaz Takir; Esen Akkaya
Journal:  Lung       Date:  2015-05-20       Impact factor: 2.584

3.  A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology.

Authors:  Riemer H J A Slart; Andor W J M Glaudemans; Patrizio Lancellotti; Fabien Hyafil; Ron Blankstein; Ronald G Schwartz; Wael A Jaber; Raymond Russell; Alessia Gimelli; François Rouzet; Marcus Hacker; Olivier Gheysens; Sven Plein; Edward J Miller; Sharmila Dorbala; Erwan Donal
Journal:  J Nucl Cardiol       Date:  2018-02       Impact factor: 5.952

Review 4.  Advanced imaging of cardiac sarcoidosis.

Authors:  Chadi Ayoub; Elena Pena; Hiroshi Ohira; Alexander Dick; Eugene Leung; Pablo B Nery; David Birnie; Rob S B Beanlands
Journal:  Curr Cardiol Rep       Date:  2015       Impact factor: 2.931

Review 5.  Pathophysiology and clinical management of cardiac sarcoidosis.

Authors:  Nabeel Hamzeh; David A Steckman; William H Sauer; Marc A Judson
Journal:  Nat Rev Cardiol       Date:  2015-02-24       Impact factor: 32.419

Review 6.  The roles of global longitudinal strain imaging in contemporary clinical cardiology.

Authors:  Toshimitsu Kato; Tomonari Harada; Kazuki Kagami; Masaru Obokata
Journal:  J Med Ultrason (2001)       Date:  2022-01-28       Impact factor: 1.314

7.  The Role of Serum Galectin-3 Levels in Patients with Sarcoidosis.

Authors:  Kaan Kara; Seda Tural Onur; Sinem Nedime Sokucu; Ozlem Kahya; Cengiz Ozdemir; Evin Ademoglu
Journal:  Med Princ Pract       Date:  2021-12-16       Impact factor: 1.927

8.  Effects of hyperaemia on left ventricular longitudinal strain in patients with suspected coronary artery disease : A first-pass stress perfusion cardiovascular magnetic resonance imaging study.

Authors:  P Garg; R Aziz; T Al Musa; D P Ripley; P Haaf; J R J Foley; P P Swoboda; G J Fent; L E Dobson; J P Greenwood; S Plein
Journal:  Neth Heart J       Date:  2018-02       Impact factor: 2.380

Review 9.  The Roles of Tenascins in Cardiovascular, Inflammatory, and Heritable Connective Tissue Diseases.

Authors:  Ken-Ichi Matsumoto; Hiroki Aoki
Journal:  Front Immunol       Date:  2020-12-01       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.